Fierce Biotech December 8, 2023
Andrea Park

This week, Tandem Diabetes Care’s t:slim X2 insulin pump and Control-IQ algorithm made headlines as they became the first to integrate with Dexcom’s G7 sensor to create an artificial pancreas system. A mere 24 hours later, they’re already having to share the spotlight.

On Thursday, the day after Dexcom announced the Tandem team-up, Beta Bionics revealed that its technology, too, has been tapped to link with the G7 continuous glucose monitor. In this case, the resulting automated insulin delivery system will comprise Dexcom’s sensor plus Beta Bionics’ insulin pump and dosing software, which together have been dubbed the iLet Bionic Pancreas and were previously compatible only with Dexcom’s G6 sensor.

The iLet system was cleared by the FDA earlier this...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
OCT Medical Devices 2025: AI’s value appreciable, yet human touch remains key
GE HealthCare invests $138M in new contrast media manufacturing site amid rising demand
Medical Device Makers Seek Exemption From Trump Tariffs
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs
Medical device cyber updates must consider patient safety

Share This Article